Public consultation on harmonised classification and labelling

The European Chemicals Agency (ECHA) is looking for comments on the harmonised classification and labelling proposals for:

  • Emamectin benzoate (ISO); (4’’R)-4’’-deoxy-4’’-(methylamino) avermectin B1 benzoate (EC -; CAS 155569-91-8). It has no harmonised classification and labelling in Annex VI to CLP. Comments are invited on selected physical hazards as well as hazards on human health and the environment except respiratory sensitisation, aspiration and hazardous to the ozone layer.
  • Trinexapac-ethyl (ISO); ethyl 4-[cyclopropyl(hydroxy)methylene]-3,5-dioxocyclohexanecarboxylate; (1RS, 4EZ)-4-[cyclopropyl(hydroxy)methylene]-3,5-dioxocyclohexanecarboxylate (EC -; CAS 95266-40-3). It has no harmonised classification and labelling in Annex VI to CLP. Comments are invited on selected physical hazards as well as all human health hazards and hazards to the aquatic environment except respiratory sensitisation, aspiration and hazardous to the ozone layer.
  • [S-(Z,E)]-5-(1-hydroxy-2,6,6-trimethyl-4-oxocyclohex-2-en-1-yl)-3-methylpenta-2,4-dienoic acid; S-abscisic acid (EC 244-319-5; CAS 21293-29-8). It has no existing harmonised classification and labelling in Annex VI to CLP. Comments are invited on selected physical hazards as well as on human health hazards and hazards to the aquatic environment except carcinogenicity, respiratory sensitisation, aspiration and hazardous to the ozone layer.

The deadline for comments is 11 January 2019

Comments can be submitted at: Give comments

ECHA News, 31 October 2018 ; http://echa.europa.eu